Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Gains from Investment Securities (2016 - 2025)

Cosmos Health (COSM) has disclosed Gains from Investment Securities for 11 consecutive years, with $2555.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 457.86% year-over-year to $2555.0, compared with a TTM value of $40666.0 through Sep 2025, up 355.79%, and an annual FY2024 reading of $12.9 million, up 50.98% over the prior year.
  • Gains from Investment Securities was $2555.0 for Q3 2025 at Cosmos Health, up from -$584.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $70551.0 in Q3 2021 and bottomed at -$75801.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $4815.8, with a median of $5036.0 recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 915.0% in 2023, while the deepest fall reached 150.7% in 2023.
  • Year by year, Gains from Investment Securities stood at -$75801.0 in 2021, then soared by 106.36% to $4822.0 in 2022, then surged by 48.42% to $7157.0 in 2023, then soared by 365.24% to $33297.0 in 2024, then tumbled by 92.33% to $2555.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for COSM at $2555.0 in Q3 2025, -$584.0 in Q2 2025, and $5398.0 in Q1 2025.